Seroquel XR, also known as quetiapine fumarate, is an atypical antipsychotic medication used in the treatment of various mental health disorders, including schizophrenia, bipolar disorder, and major depressive disorder. The drug is marketed by AstraZeneca and has been a significant player in the pharmaceutical market due to its broad therapeutic applications.
Quetiapine fumarate reach the market in Q3 2020. The global market size was valued at approximately USD 3.5 billion in 2023[4].
North America dominates the mental health sector, accounting for approximately 40% of the market in that region last year. The growth is driven by the high awareness of mental health, particularly in key market segments.
The Europe region shows significant growth due to growing awareness of mental health and the increasing geriatric population. The region's mental health population aged 65 and older has experienced significant changes in recent years[2].
North America and the United States are the largest market nations driving up demand. These nations have trended to have the highest market share due to growing awareness of medical disorders and growing user preferences.
The globalSchizophrenia mental health market size was valued at USD 160 million in 2023. The market is expected to grow at a steady rate of 7.0% a year through the forecast period[4].
The Quetiapine XR drug market is projected to grow to reach USD 1 billion by the end of 2023[4].
Bacterial infections are a growing global health concern, with the number of infections climbing from just under 500 million in 2011 to 2.4 billion by 2031, creating a continued threat to your health[2.].
| Market Size | Q3 2020 |
| Quetiapine Fumarate | 40% |
| Seroquel XR | 36% |
The primary factors driving the demand for Quetiapine XR include improving mental health, managing dementia-related complications, and maintaining high pharmaceutical compliance[2].
The future outlook for the mental health sector is characterized by inactivity. The increasing prevalence of mental health disorders, rising awareness of neurological conditions, and the competitive landscape will continue to support market expansion[2].
| Market Lead | Doll |
|---|---|
The price of Quetiapine fumarate could be significantly impacted when regulations continue to adapt. The drug's effectiveness and safety profiles will be a concern due to its growing awareness of mental health, improved focus on treating neurological conditions, and the regulatory process allowing greater flexibility in dosage levels. Low cost generic alternatives to Quetiapine Fumarate may emerge, including alternative antipsychotic medications that target in vitro antipsychotic effects and increased patient adherence to the treatment regimen[2][5].
Medically reviewed by Jessica Swirble, PharmDLast updated on April 18, 2025
Drug Information| | |
Quetiapine is an atypical antipsychotic drug that is used to treat schizophrenia, bipolar disorder, and major depressive disorder (.
Quetiapine is often prescribed to people with schizophrenia, bipolar disorder, and depression to help them manage their condition and mental health needs. It is also used to treat symptoms of depression in bipolar disorder patients. Seroquel is a controlled substance that was formerly used to treat depression, but has now been approved for the treatment of schizophrenia, bipolar disorder, and major depressive disorder.
Quetiapine is classified as a atypical antipsychotic, which means it has an atypical side effect profile. The side effects of quetiapine can include weakness, loss of appetite, vomiting, drowsiness, and difficulty breathing. Other quetiapine side effects can include feeling nauseated, weight gain, and suicidal thoughts once they occur. Quetiapine is not recommended for children under the age of 18 years.
Quetiapine is used to treat conditions such as irritability associated with adulthood, borderline personality disorder, major depressive disorder, bipolar disorder, premenstrual dysphoric disorder, premenstrual syndrome, and other signs of brain stress. The use of quetiapine can also be used to treat symptoms of depression in depression disorder patients. Seroquel is sometimes used as an adjunct treatment to other antidepressants to help reduce symptoms of depression.
Quetiapine is available in both generic and a generics form. Generics are available by combining the generic and brand names. The generic versions of quetiapine are also available under brand names such as Seroquel and Quetiapine.
See also page 7 for healthy alternatives to quetiapine, such as sigma (seroquel), quetiapine (Catapres, Seroquel), and lorazepam (Quetiapine HCl).
Quetiapine is not recommended for use in children under the age of 18 years.
Quetiapine is not recommended for use in children.
Quetiapine is not available in price-controlled regions. However, some refills can be made more accessible if you check out.
Quetiapine is a prescription medication. Quetiapine is used to treat symptoms of depression in depression disorder patients. It is also sometimes used to treat symptoms of obsessive-compulsive disorder, panic disorder, bipolar disorder, mania disease, and epilepsy.
Find out more about Quetiapine.
Quetiapine has a known adverse effect on the central nervous system as decreased excitability, seizures, and dizziness. It can also cause drowsiness and weight gain in some cases. Drowsiness is a known adverse effect of quetiapine. It can be caused by certain medical conditions, such as heart disease, certain other conditions, or a genetic tendency.
orry-based index (orry-and worry) has information on 20,000, 7.3 million, and 10.7 million people worried about their health or their problems for seven years, using information from the Index. index includes information on 1.7 million people using the Index as a way to keep up with a index increase.
See also bonus information in the back of the product packaging.
backing onlineippertSee also page 9.
backAstraZeneca has agreed to pay $2.6 billion to settle allegations it failed to warn patients of the risks of the diabetes drug quetiapine.
AstraZeneca is the world's biggest drug maker, with more than $2.2 billion in global sales in 2017.
Quetiapine, or Seroquel, was approved by the U. S. Food and Drug Administration in 1996 as an antipsychotic drug, but it has remained on the market for more than a decade. It has been linked to increased mortality, and researchers believe it may also have dangerous side effects such as hyperglycemia, diabetes-related breathing problems, and even death.
Quetiapine is an atypical antipsychotic that works by increasing dopamine and serotonin levels, while blocking serotonin uptake, which can lead to extrapyramidal symptoms.
AstraZeneca has agreed to pay $2.6 billion to resolve at least three separate lawsuits in the United States, including one claiming that the company failed to adequately warn patients of the risks of the drug, a claim that has been challenged in other lawsuits.
The allegations are based on AstraZeneca's own drug, which had been approved for use in more than 50 countries in the world. In August, the company paid $2.6 billion to resolve six of the drug lawsuits.
The settlement was announced on Wednesday, with the company providing a letter of consent to all its members.
In the United States, AstraZeneca is the world's second-largest drug maker, after Eli Lilly & Co.
AstraZeneca has agreed to pay $2.6 billion to settle allegations it failed to warn patients of the risks of the diabetes drug quetiapine, the company said on Thursday.
The settlement is an arrangement that will pay $2.6 billion to resolve at least three separate lawsuits over the drug's use, said David Kammerer, the company's executive vice president for global sales.
The allegations are based on claims that the company failed to warn patients about the risks of quetiapine, which the company said included diabetes, the symptoms of heart failure, and death.
The lawsuit has been filed in the United States, where AstraZeneca has a $5 billion-a-year business. The allegations, though, are not based on a breach of the settlement agreement, and the case is still pending.
AstraZeneca declined to provide further details about the settlement.
However, a spokeswoman for AstraZeneca said, "The agreement is an appropriate arrangement for the company, as it is a world leader in the area."
The settlement was announced on Wednesday, with the company providing a letter of consent to all members.
AstraZeneca has agreed to pay $2.6 billion to resolve at least three separate lawsuits over the drug, including one claiming that the company failed to adequately warn patients of the risk of the drug, a claim that has been challenged in other lawsuits.
The allegations are based on claims that the company failed to warn patients about the risks of the drug, a claim that has been challenged in other lawsuits.
The settlement is an arrangement that will pay $2.6 billion to resolve at least three separate lawsuits over the drug's use, including one claiming that the company failed to adequately warn patients of the risk of the drug, a claim that has been challenged in other lawsuits.
The allegations are based on allegations that the company failed to warn patients of the risks of the drug, a claim that has been challenged in other lawsuits.
The allegations are based on claims that the company failed to warn patients of the risks of the drug, a claim that has been challenged in other lawsuits.
The American Psychiatric Association has been criticized for its use of the term "schizophrenia." It is now referred to as "Schizophrenia."
If you are suffering from severe symptoms of psychosis, you will not be able to help you with your condition, and you may not even know how to treat it. However, you are in a position to help with your condition.
Schizophrenia is one of the most common mental disorders in the United States, and is a debilitating and lifelong disease. It is characterized by intense symptoms and constant hallucinations, often accompanied by a pounding pulse, delusions, and disorganized thinking.
For most Americans, a person with schizophrenia will experience one or more of these symptoms:
There are several types of psychosis. A person with schizophrenia may have:
While it is not necessary to diagnose the disease, a person with schizophrenia may be diagnosed with the following:
There is no cure for schizophrenia, but it may be treated by a psychotherapist or therapist. However, it is also possible to treat a person with a manic or mixed psychotic disorder (BPD) in which case a person is diagnosed with BPD and treated with a medication such as Seroquel.
If you are diagnosed with BPD, you may be able to work with your psychiatrist to find a treatment plan that works for you.
The good news is that you may be able to:
There are two types of mental health problems that have the same symptoms as Schizophrenia:
Although there are a few treatments that can help a person with Schizophrenia, there are still a few treatments that are not proven to be effective for everyone. These treatments are:
There are two types of treatment for Schizophrenia:
There are a few types of treatment for Schizophrenia:
Antidepressants are also used to treat Schizophrenia in some situations.
Stade de France Pharmacy